Imagine being able to detect a life-changing disease with just an exhale. That's how doctors plan to diagnose multiple sclerosis.

It's common for people with multiple sclerosis (MS) to have trouble walking or maintaining balance. For most MS sufferers, this is the most difficult aspect of living with the disease.

Scientists believe that maintaining sufficient levels of vitamin D can lower the risk of developing multiple sclerosis (MS). But can high doses help people who already have the disease?

A cutting-edge stem cell therapy for treating multiple sclerosis (MS) is one step closer to reality. New research targets myelin, a material that coats neurons in the brain.

The overnight shift might seem like an easy way to make money, but a new study warns that disrupting your sleep cycle as a teen can increase your risk of developing multiple sclerosis.

The sooner you treat a disease like multiple sclerosis (MS), the better the outcome, right? Well, that statement appears to be somewhat true.

It is good news when researchers gain a little more knowledge about the development of one disease. It is even better news when that little bit of knowledge applies to a whole group of diseases.

The dietary supplement glucosamine is popular for helping aching, arthritic joints. A new supplement looks like it could suppress the damaging autoimmune response seen in multiple sclerosis (MS).

People with multiple sclerosis (MS) experience their symptoms in episodes. To curb these episodes, there are a few medications patients can take. Now, there may be a new drug option for people with MS.

Studies have shown a possible connection between blocked veins and multiple sclerosis (MS). But these studies may have been designed poorly, leaving this topic in need of more research.